Apart from any moral considerations this is a stupid method of training, for it produces a resentful animal who at a later stage may well turn man-killer.

On October 13th a study published in Science Translational Medicine revealed that early-stage trials show a new tuberculosis vaccine may work against drug-resistant strains of that killer disease.

The new boss pointed to torcetrapib, a cholesterol drug in late-stage trials, and gushed that it could “redefine the way we treat the world's number-one killer—cardiovascular disease.”